DENND2B activates Rab13 at the leading edge of migrating cells and promotes metastatic behavior

por Ioannou, Maria S., Bell, Emily S., Girard, Martine, Chaineau, Mathilde, Hamlin, Jason N.R., Daubaras, Mark, Monast, Anie, Park, Morag, Hodgson, Louis, McPherson, Peter S.
Publicado 2015

Met–HER3 crosstalk supports proliferation via MPZL3 in MET-amplified cancer cells

por Stern, Yaakov E., Al-Ghabkari, Abdulhameed, Monast, Anie, Fiset, Benoit, Aboualizadeh, Farzaneh, Yao, Zhong, Stagljar, Igor, Walsh, Logan A., Duhamel, Stephanie, Park, Morag
Publicado 2022

Co-dependency for MET and FGFR1 in basal triple-negative breast cancers

por Sung, Vanessa Y. C., Knight, Jennifer F., Johnson, Radia M., Stern, Yaakov E., Saleh, Sadiq M., Savage, Paul, Monast, Anie, Zuo, Dongmei, Duhamel, Stéphanie, Park, Morag
Publicado 2021

5′-Inositol phosphatase SHIP2 recruits Mena to stabilize invadopodia for cancer cell invasion

por Rajadurai, Charles V., Havrylov, Serhiy, Coelho, Paula P., Ratcliffe, Colin D.H., Zaoui, Kossay, Huang, Bruce H., Monast, Anie, Chughtai, Naila, Sangwan, Veena, Gertler, Frank B., Siegel, Peter M., Park, Morag
Publicado 2016

Crk adaptor proteins act as key signaling integrators for breast tumorigenesis

por Fathers, Kelly E, Bell, Emily S, Rajadurai, Charles V, Cory, Sean, Zhao, Hong, Mourskaia, Anna, Zuo, Dongmei, Madore, Jason, Monast, Anie, Mes-Masson, Anne-Marie, Grosset, Andree-Anne, Gaboury, Louis, Hallet, Michael, Siegel, Peter, Park, Morag
Publicado 2012

Chemogenomic profiling of breast cancer patient-derived xenografts reveals targetable vulnerabilities for difficult-to-treat tumors

por Savage, Paul, Pacis, Alain, Kuasne, Hellen, Liu, Leah, Lai, Daniel, Wan, Adrian, Dankner, Matthew, Martinez, Constanza, Muñoz-Ramos, Valentina, Pilon, Virginie, Monast, Anie, Zhao, Hong, Souleimanova, Margarita, Annis, Matthew G., Aguilar-Mahecha, Adriana, Lafleur, Josiane, Bertos, Nicholas R., Asselah, Jamil, Bouganim, Nathaniel, Petrecca, Kevin, Siegel, Peter M., Omeroglu, Atilla, Shah, Sohrab P., Aparicio, Samuel, Basik, Mark, Meterissian, Sarkis, Park, Morag
Publicado 2020

Author Correction: SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca(2+) flux to mitochondria

por Xue, Yibo, Morris, Jordan L., Yang, Kangning, Fu, Zheng, Zhu, Xianbing, Johnson, Fraser, Meehan, Brian, Witkowski, Leora, Yasmeen, Amber, Golenar, Tunde, Coatham, Mackenzie, Morin, Geneviève, Monast, Anie, Pilon, Virginie, Fiset, Pierre Olivier, Jung, Sungmi, Gonzalez, Anne V., Camilleri-Broet, Sophie, Fu, Lili, Postovit, Lynne-Marie, Spicer, Jonathan, Gotlieb, Walter H., Guiot, Marie-Christine, Rak, Janusz, Park, Morag, Lockwood, William, Foulkes, William D., Prudent, Julien, Huang, Sidong
Publicado 2023

Alanine supplementation exploits glutamine dependency induced by SMARCA4/2-loss

por Zhu, Xianbing, Fu, Zheng, Chen, Shary Y., Ong, Dionzie, Aceto, Giulio, Ho, Rebecca, Steinberger, Jutta, Monast, Anie, Pilon, Virginie, Li, Eunice, Ta, Monica, Ching, Kyle, Adams, Bianca N., Negri, Gian L., Choiniere, Luc, Fu, Lili, Pavlakis, Kitty, Pirrotte, Patrick, Avizonis, Daina Z., Trent, Jeffrey, Weissman, Bernard E., Klein Geltink, Ramon I., Morin, Gregg B., Park, Morag, Huntsman, David G., Foulkes, William D., Wang, Yemin, Huang, Sidong
Publicado 2023

SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca(2+) flux to mitochondria

por Xue, Yibo, Morris, Jordan L., Yang, Kangning, Fu, Zheng, Zhu, Xianbing, Johnson, Fraser, Meehan, Brian, Witkowski, Leora, Yasmeen, Amber, Golenar, Tunde, Coatham, Mackenzie, Morin, Geneviève, Monast, Anie, Pilon, Virginie, Fiset, Pierre Olivier, Jung, Sungmi, Gonzalez, Anne V., Camilleri-Broet, Sophie, Fu, Lili, Postovit, Lynne-Marie, Spicer, Jonathan, Gotlieb, Walter H., Guiot, Marie-Christine, Rak, Janusz, Park, Morag, Lockwood, William, Foulkes, William D., Prudent, Julien, Huang, Sidong
Publicado 2021